Want to see IN:LAURUSLABS full AI Analyst Report?

Laurus Labs Ltd. (LAURUSLABS) Price & Analysis

11 Followers

LAURUSLABS Stock Chart & Stats

₹1602.30

₹112.20(7.01%)

At close: Jul 27 4:00 PM EDT

₹1602.30

₹112.20(7.01%)

Day’s Range― - ―

52-Week Range₹822.85 - ₹1,947.90

Previous CloseN/A

Volume7.99M

Average Volume (3M)98.57K

Market Cap

₹994.17B

Enterprise Value₹560.82K

Total Cash (Recent Filing)₹1.14B

Total Debt (Recent Filing)₹0.00

Price to Earnings (P/E)90.9

Beta0.95

Next Earnings

Oct 22, 2026

EPS Estimate

5.58

Next Dividend Ex-DateN/A

Dividend Yield0.11%

Share Statistics

EPS (TTM)20.25

Shares Outstanding540,312,200

10 Day Avg. Volume62,304

30 Day Avg. Volume98,567

Financial Highlights & Ratios

PEG Ratio0.41

Price to Book (P/B)10.11

Price to Sales (P/S)7.86

P/FCF Ratio137.56

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price Target

₹1,700.00

Price Target Upside6.10% Upside

Rating ConsensusHold

Number of Analyst Covering1

EPS Forecast (FY)24.69

Revenue Forecast (FY)₹83.34B

Bulls Say, Bears Say

Bulls Say

Diversified Pharmaceutical PlatformLaurus operates across APIs, finished formulations, and CDMO services, giving it several routes to capture pharmaceutical value. This mix can support customer retention, broaden end-market exposure, and reduce reliance on any single product or revenue stream over the medium term.

Profitability RecoveryThe FY2026 rebound in revenue and net margin indicates that earnings have recovered materially from the prior two years. Improving profitability can strengthen internal funding capacity and provide a better base for continued investment, although sustained execution will be needed to preserve the recovery.

Improving LeverageLower debt-to-equity and a rising equity base point to improving balance-sheet resilience. Reduced leverage can provide greater flexibility to fund capacity and development initiatives, while making the business less exposed to financing pressure than it was in earlier reported periods.

Bears Say

Weak Free Cash FlowFree cash flow remains weak relative to reported earnings and has been negative in the two preceding fiscal years. This suggests that capital spending and/or working-capital needs are absorbing cash, limiting financial flexibility and reducing the company’s ability to fund growth internally.

Gross Margin CompressionThe sharp decline in gross margin shows that the earnings recovery has not been matched by stable underlying economics. Higher input costs, pricing pressure, or an adverse product mix could continue to constrain profit conversion, leaving operating performance less durable than the headline net-margin rebound suggests.

Choppy Revenue GrowthRevenue has recovered, but the sequence of decline followed by growth indicates that demand and execution have not produced a consistently expanding trajectory. Uneven growth makes capacity planning and cash deployment harder, and increases dependence on continued recovery in subsequent reporting periods.

Laurus Labs Ltd. News

Laurus Labs Files Q1 FY27 Earnings Call Transcript with Exchanges

Laurus Labs Ltd. ( ($IN:LAURUSLABS) ) has provided an update. Laurus Labs Ltd. has notified stock exchanges that...

1M ago

Laurus Labs’ Composite Scheme of Arrangement Moves to NCLT Hearing in September

Laurus Labs Ltd. ( ($IN:LAURUSLABS) ) just unveiled an announcement. Laurus Labs Limited, a diversified pharmaceutical manufacturer with...

1M ago

Laurus Labs Posts Audio of Q1 FY27 Earnings Call for Investors

The latest announcement is out from Laurus Labs Ltd. ( ($IN:LAURUSLABS) ). Laurus Labs has notified the stock...

2M ago

Laurus Labs Concludes 21st AGM with Strong Virtual Shareholder Participation

An update from Laurus Labs Ltd. ( ($IN:LAURUSLABS) ) is now available. Laurus Labs Ltd. held its 21st...

2M ago

Laurus Labs strengthens board with new independent directors

An announcement from Laurus Labs Ltd. ( ($IN:LAURUSLABS) ) is now available. Laurus Labs Ltd., a publicly listed...

2M ago

Laurus Labs shuts trading window ahead of June-quarter results

Laurus Labs Ltd. ( ($IN:LAURUSLABS) ) has shared an update. Laurus Labs Ltd. has announced the closure of...

2M ago

Laurus Labs Closes Trading Window Ahead of FY26 Results

Laurus Labs Ltd. ( ($IN:LAURUSLABS) ) has provided an announcement. Laurus Labs Limited has announced that its trading...

5M ago

Laurus Labs Releases Q2 FY26 Results Conference Call Recording

Laurus Labs Ltd. ( ($IN:LAURUSLABS) ) has provided an announcement. Laurus Labs Ltd. announced the availability of the...

11M ago

Laurus Labs Secures Land for Major Expansion in Andhra Pradesh

Laurus Labs Ltd. ( ($IN:LAURUSLABS) ) has issued an update. Laurus Labs Ltd. has been allotted 531.77 acres...

1y ago

Laurus Labs Conducts 20th AGM with Key Stakeholders

Laurus Labs Ltd. ( ($IN:LAURUSLABS) ) has issued an announcement. Laurus Labs Ltd. held its 20th Annual General...

1y ago

LAURUSLABS FAQ

What was Laurus Labs Ltd.’s price range in the past 12 months?

Laurus Labs Ltd. lowest stock price was ₹822.85 and its highest was ₹1947.90 in the past 12 months.

What is Laurus Labs Ltd.’s market cap?

Laurus Labs Ltd.’s market cap is ₹994.17B.

When is Laurus Labs Ltd.’s upcoming earnings report date?

Laurus Labs Ltd.’s upcoming earnings report date is Oct 22, 2026 which is in 45 days.

How were Laurus Labs Ltd.’s earnings last quarter?

Laurus Labs Ltd. released its earnings results on Jul 24, 2026. The company reported ₹6.8 earnings per share for the quarter, beating the consensus estimate of ₹4.912 by ₹1.888.

Is Laurus Labs Ltd. overvalued?

According to Wall Street analysts Laurus Labs Ltd.’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does Laurus Labs Ltd. pay dividends?

Laurus Labs Ltd. pays a Semiannually dividend of ₹1.2 which represents an annual dividend yield of 0.11%. See more information on Laurus Labs Ltd. dividends here

What is Laurus Labs Ltd.’s EPS estimate?

Laurus Labs Ltd.’s EPS estimate is 5.58.

How many shares outstanding does Laurus Labs Ltd. have?

Laurus Labs Ltd. has 540,312,200 shares outstanding.

What happened to Laurus Labs Ltd.’s price movement after its last earnings report?

Laurus Labs Ltd. reported an EPS of ₹6.8 in its last earnings report, beating expectations of ₹4.912. Following the earnings report the stock price went up 2.168%.

Which hedge fund is a major shareholder of Laurus Labs Ltd.?

Currently, no hedge funds are holding shares in IN:LAURUSLABS

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Laurus Labs Ltd.

Established in 2005 and headquartered in Hyderabad, India, Laurus Labs Limited, along with its subsidiaries, operates as a diversified global pharmaceutical company. It focuses on the research, manufacturing, and international distribution of a broad spectrum of medicines and active pharmaceutical ingredients (APIs). The company's API and advanced intermediate offerings cover key therapeutic domains such as anti-retroviral (ARV), antidiabetic, cardiovascular, proton pump inhibitors (PPIs), oncology, gastroenterology, and hepatitis C. Additionally, Laurus Labs develops and produces oral solid dosage forms targeting ARV, antidiabetic, cardiovascular, PPI, and central nervous system (CNS) conditions. Beyond its proprietary products, the firm extends its expertise through contract development and manufacturing services for other pharmaceutical enterprises. It also supplies specialized ingredients vital for nutraceutical, dietary supplement, and cosmeceutical applications. Furthermore, Laurus Labs is at the forefront of innovation, engineering novel enzymatic solutions for industrial biotechnology, and providing animal-origin-free recombinant proteins and enzymes for biopharmaceutical use, alongside offering a range of business support services within the pharmaceutical industry.

Laurus Labs Ltd. (LAURUSLABS) Earnings & Revenues

Historic Earnings Reports

LAURUSLABS Stock 12 Month Forecast

Average Price Target

₹1,700.00

▲(6.10% Upside)

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"857":"₹857","1108":"₹1,108","1359":"₹1,359","1610":"₹1,610","1861":"₹1,861"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":1700,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">₹1.70K</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":1700,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">₹1.70K</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":1700,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">₹1.70K</span>\n  </div></div>","useHTML":true}}],"tickPositions":[857,1108,1359,1610,1861],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Dec<br/>2025","6":"Mar<br/>2026","9":"Jun<br/>2026","12":"Sep<br/>2026","25":"Sep<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,1860,1847.6923076923076,1835.3846153846155,1823.076923076923,1810.7692307692307,1798.4615384615386,1786.1538461538462,1773.8461538461538,1761.5384615384614,1749.2307692307693,1736.923076923077,1724.6153846153845,1712.3076923076924,{"y":1700,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,1860,1847.6923076923076,1835.3846153846155,1823.076923076923,1810.7692307692307,1798.4615384615386,1786.1538461538462,1773.8461538461538,1761.5384615384614,1749.2307692307693,1736.923076923077,1724.6153846153845,1712.3076923076924,{"y":1700,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,1860,1847.6923076923076,1835.3846153846155,1823.076923076923,1810.7692307692307,1798.4615384615386,1786.1538461538462,1773.8461538461538,1761.5384615384614,1749.2307692307693,1736.923076923077,1724.6153846153845,1712.3076923076924,{"y":1700,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":858.635,"date":1756684800000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 5</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":870.464,"date":1759276800000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":953.55,"date":1761955200000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":1027.926,"date":1764547200000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":1108.995,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":952.951,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1063.89,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1038.216,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1098.006,"date":1777593600000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":1388.4,"date":1780272000000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":1493.6,"date":1782864000000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":1816.1,"date":1785542400000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":1860,"date":1788220800000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Detailed Analyst Forecast >